Life Science REIT PLC (LABS) — Financial Flexibility Index
Life Science REIT PLC (LABS) has a Financial Flexibility Index of 0.05x as of June 2025. Free cash flow of GBX6.76 Million (operating CF GBX958.00K minus capex GBX5.81 Million) represents 0% of total liabilities (GBX141.89 Million). Also explore net asset growth rate of Life Science REIT PLC to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Life Science REIT PLC Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Life Science REIT PLC across 4 annual periods. Check how strategically is Life Science REIT PLC's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Life Science REIT PLC (2021–2024)
Year-by-year free cash flow to debt coverage for Life Science REIT PLC. For the full company profile including market capitalisation, see LABS stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | GBX32.20 Million | GBX12.92 Million | GBX138.42 Million | ▼ -6.7% |
| 2023 | 0.25x | GBX31.65 Million | GBX7.62 Million | GBX126.96 Million | ▲ +388.4% |
| 2022 | 0.05x | GBX6.55 Million | GBX-1.09 Million | GBX128.37 Million | ▼ -95.1% |
| 2021 | 1.03x | GBX11.18 Million | GBX3.54 Million | GBX10.82 Million | — |